Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Expert group consensus from the Arabian Peninsula on the diagnosis of LOPD

Diagnostic Algorithm for Gaucher Disease in Pediatric

Diagnostic Algorithm for Gaucher Disease in Adult

ATTD 2021: Technology Supporting Initiation, Titration, and Intensification

Hear from an expert on how can you limit the effects of systemic steroid use for Patients with CRS with Nasal Polyps?

The superiority of Biologics over OCS for disease modifying potential which explains the superiority over OCS as anti-inflammatory option for our patients with CRSwNP, when we prescribe the Biologicals, we prescribe them long term for chronic disease where we do believe that we do not only aim to reduce inflammation but also to have some disease modifying effects.

Bone Monitoring Guidelines in Gaucher Disease Video

Rethink your Nasal Polyps. Type 2 Inflammation a Nasal Polyp mystery

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

The reason for MS – beyond focal inflammation

MPSI chase the signs video

There is Significant Unmet Need in the Management of PN¹

Possible Challenges Post One Year of ESC/EAS Guidelines